血小板因子XIII-A调节血小板功能,促进血块收缩和稳定
Joanne L Mitchell1, Gemma Little2, Alexander P Bye3
1Institute for Cardiovascular Research, University of Birmingham, Birmingham, UK.
Research and practice in thrombosis and haemostasis
|August 21, 2023
概括
血小板因子XIII-A (FXIII-A) 增强了血小板激活,纤维素原结合和凝块收缩. 这项研究揭示了FXIII-A在血栓形成和血小板功能中的关键作用,超出了其已知的抗纤维解质作用.
科学领域:
- 血液学 血液学 血液学
- 血液静止和血栓形成
- 血小板生物学 血小板生物学
背景情况:
- 第十三因子 (FXIII) 对于血液静止至关重要,强化血栓并抵抗纤维素分解.
- 细胞FXIII-A被激活的血小板外化,但其在血小板功能中的特定作用仍未得到充分研究.
研究的目的:
- 阐明血小板衍生的FXIII-A在血小板激活和整体血液静止中的作用.
主要方法:
- 使用了正常的血小板与FXIII抑制剂和FXIII缺乏的血小板.
- 通过各种测试评估血小板功能和凝血,包括在流动下形成全血栓.
主要成果:
- 血小板FXIII-A增强了激素激剂诱导的纤维素原结合和血小板聚合.
- 缺乏FXIII-A会降低血小板对激动剂的敏感性,减少P-选择素的暴露,以及血小板的扩散.
- 缺少FXIII-A会影响血块收缩.
结论:
- 血小板FXIII-A通过促进血小板激活和凝块收缩,在血栓形成中发挥着重要作用.
- FXIII-A有助于血小板功能,超出其既定的抗纤维素分解作用.
相关概念视频
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
Formation of the Platelet Plug
6.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.7K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
751
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
751
Extrinsic and Intrinsic Pathways of Hemostasis
8.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.3K
Coagulation
7.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
7.1K


